Huapont Life Sciences Co Ltd Capital Reinvestment Ratio
Huapont Life Sciences Co Ltd capital reinvestment ratio. Huapont Life Sciences Co Ltd (002004) has a Capital Reinvestment Ratio of 0.25x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥635.17 Million) in capital expenditures (CN¥160.05 Million). Check 002004 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Huapont Life Sciences Co Ltd (2002–2025)
Capital reinvestment ratio of Huapont Life Sciences Co Ltd from 2002 to 2025. This chart tracks Huapont Life Sciences Co Ltd's Capital Reinvestment Ratio across 24 annual periods. Also explore Huapont Life Sciences Co Ltd (002004) equity growth momentum to track the company's year-over-year net asset growth rate.
Huapont Life Sciences Co Ltd Capital Reinvestment Ratio by Year (2002–2025)
Huapont Life Sciences Co Ltd capital reinvestment ratio by year from 2002 to 2025. For the full cash flow conversion analysis, see Huapont Life Sciences Co Ltd cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.30x | CN¥2.10 Billion | CN¥638.28 Million | ▼ -48.2% |
| 2024 | 0.59x | CN¥1.63 Billion | CN¥956.27 Million | ▼ -27.2% |
| 2023 | 0.81x | CN¥1.59 Billion | CN¥1.28 Billion | ▲ +72.0% |
| 2022 | 0.47x | CN¥2.41 Billion | CN¥1.13 Billion | ▼ -52.5% |
| 2021 | 0.99x | CN¥1.27 Billion | CN¥1.26 Billion | ▲ +90.7% |
| 2020 | 0.52x | CN¥2.37 Billion | CN¥1.23 Billion | ▼ -24.6% |
| 2019 | 0.69x | CN¥2.08 Billion | CN¥1.43 Billion | ▲ +19.5% |
| 2018 | 0.58x | CN¥1.91 Billion | CN¥1.10 Billion | ▼ -65.0% |
| 2017 | 1.64x | CN¥591.40 Million | CN¥972.67 Million | ▲ +29.3% |
| 2016 | 1.27x | CN¥511.90 Million | CN¥651.24 Million | ▼ -47.6% |
| 2015 | 2.43x | CN¥342.45 Million | CN¥831.76 Million | ▲ +89.1% |
| 2014 | 1.28x | CN¥455.96 Million | CN¥585.54 Million | ▲ +18.2% |
| 2013 | 1.09x | CN¥349.51 Million | CN¥379.81 Million | ▼ -11.1% |
| 2012 | 1.22x | CN¥257.75 Million | CN¥315.21 Million | ▲ +72.7% |
| 2011 | 0.71x | CN¥135.23 Million | CN¥95.77 Million | ▼ -0.6% |
| 2010 | 0.71x | CN¥79.84 Million | CN¥56.87 Million | ▲ +19.8% |
| 2009 | 0.59x | CN¥123.53 Million | CN¥73.46 Million | ▼ -26.9% |
| 2008 | 0.81x | CN¥113.76 Million | CN¥92.49 Million | ▼ -48.1% |
| 2007 | 1.57x | CN¥79.21 Million | CN¥124.02 Million | ▲ +116.7% |
| 2006 | 0.72x | CN¥66.10 Million | CN¥47.76 Million | ▼ -28.9% |
| 2005 | 1.02x | CN¥43.69 Million | CN¥44.42 Million | ▲ +167.6% |
| 2004 | 0.38x | CN¥70.60 Million | CN¥26.83 Million | ▼ -30.1% |
| 2003 | 0.54x | CN¥56.68 Million | CN¥30.82 Million | ▼ -62.0% |
| 2002 | 1.43x | CN¥36.88 Million | CN¥52.71 Million | — |